Journal of Medical Economics
Volume 24, 2021 - Issue 1
Open access
2,073
Views
1
CrossRef citations to date
0
Altmetric
Neurology
Novel acute therapies in the treatment of migraine: impact of re-dosing on cost–utility outcomes
Karissa M. Johnstona Broadstreet HEOR, Vancouver, CanadaCorrespondence[email protected]
View further author information
, View further author information
Gilbert L'italienb Biohaven, New Haven, CT, USAView further author information
, Linda Harrisb Biohaven, New Haven, CT, USAView further author information
, Alison Deightona Broadstreet HEOR, Vancouver, CanadaView further author information
, Evan Popoffa Broadstreet HEOR, Vancouver, CanadaView further author information
, Robert Croopb Biohaven, New Haven, CT, USAView further author information
& Vladimir Coricb Biohaven, New Haven, CT, USAView further author information
show all
Pages 512-513
|
Received 23 Dec 2020, Accepted 05 Mar 2021, Published online: 23 Apr 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.